A Phase 1B Study of Anti-Dll4 (DELTA-LIKE LIGAND 4) Antibody Demcizumab (DEM) with Pemetrexed (PEM) and Carboplatin (CARBO) in Patients with 1St-Line Non-Squamous Nsclc
Titel:
A Phase 1B Study of Anti-Dll4 (DELTA-LIKE LIGAND 4) Antibody Demcizumab (DEM) with Pemetrexed (PEM) and Carboplatin (CARBO) in Patients with 1St-Line Non-Squamous Nsclc
Auteur:
Dupont, J. McKeage, M. Kotasek, D. Markman, B. Hidalgo, M. Millward, M. Jameson, M. Harris, D. Stagg, R. Hughes, B.